UiPath Continues Its Momentum With AI-Powered Automation Growth
PATH powers growth with its AI-driven automation platform, posting rising revenues, strong adoption and a major buyback plan.
UiPath Stock Falls 11% in 3 Months: Should You Buy the Dip or Wait?
UiPath stock slides 11% in three months, but strong automation demand, key tech partnerships and solid finances keep it in focus.
Automation Boom Fuels PATH's Performance in Growing RPA Market
UiPath's alliances with tech giants, rising revenues, and strong customer retention fuel its edge in the fast-growing automation market.
UiPath (PATH) Stock Drops Despite Market Gains: Important Facts to Note
UiPath (PATH) reached $10.73 at the closing of the latest trading day, reflecting a -2.37% change compared to its last close.
Is Trending Stock UiPath, Inc. (PATH) a Buy Now?
UiPath (PATH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
UiPath (PATH) Sees a More Significant Dip Than Broader Market: Some Facts to Know
The latest trading day saw UiPath (PATH) settling at $10.93, representing a -2.58% change from its previous close.
UiPath (PATH) Suffers a Larger Drop Than the General Market: Key Insights
UiPath (PATH) reached $11.77 at the closing of the latest trading day, reflecting a -2.04% change compared to its last close.
UiPath: Waiting For Agentic AI Catalysts In H2
There is no denying that PATH has missed the first train for Agentic AI monetization, as observed in the decelerating growth hinted by the management's FY2026 guidance. With competition also heating up, it remains to be seen if PATH may report a renewed H2'25 growth opportunity through the recently released Agentic Automation in April 2025. On the other hand, PATH's market leadership in the RPA market remains compelling, significantly aided by the growing ARR and the rich cash flows.
UiPath: Agentic AI Strategy Is Taking Off, With FCF Growing As Well
I recommend rotating into catalyst-driven small- and mid-cap stocks like UiPath to protect capital as the S&P 500 hits new highs. UiPath stands out with improving sales momentum, profitability, and a raised full-year outlook, making it a compelling buy despite recent volatility. The company is also growing FCF at a double-digit pace while trading at a very modest ~12x forward FCF.
UiPath, Inc. (PATH) is Attracting Investor Attention: Here is What You Should Know
UiPath (PATH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
UiPath vs. AppLovin: Which AI-Driven Tech Stock is Purchase-Worthy?
PATH's enterprise AI edge and valuation advantage over APP make it the smarter buy in this AI-driven tech faceoff.
UiPath Stock Screams Undervalued as Market Overlooks Its RPA Dominance
PATH trades well below peers like NOW and PEGA, despite leading RPA adoption across finance, healthcare, and logistics.
